Positive Trial Results for Older Adult RSV Vaccine

November 1, 2022

Global biopharmaceutical company GSK plc recently announced that the European Medicines Agency (EMA) has validated the marketing authorization application (MAA) for its respiratory syncytial virus (RSV) older adult vaccine candidate. In October, the company had already announced positive pivotal phase three trial results for the vaccine candidate in adults aged 60 years and older.

The trial data, presented at IDWeek 2022, showed overall vaccine efficacy against RSV-lower respiratory tract disease (LRTD) in adults aged 60 years and above at 82.6%, with a favorable safety profile. Consistent high vaccine efficacy was observed against LRTD in severe disease (94.1%), adults aged 70–79 years (93.8%), and in adults with underlying comorbidities (94.6%). High vaccine efficacy was found to be consistent across RSV A and B strains.

According to the U.S. Centers for Disease Control and Prevention (CDC), RSV is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults. CDC surveillance has shown an increase this fall in RSV detections and RSV-associated emergency department visits and hospitalizations in multiple U.S. regions, with some regions nearing seasonal peak levels.

There are several steps that can be taken to reduce the risk of RSV spread in your facility. Check out RSV Cleaning and Prevention and Defend Your Facility Against Respiratory Virus for more information.

Latest Articles

States Take the Lead on Climate Risk Reporting
July 14, 2025 Stephen P. Ashkin

States Take the Lead on Climate Risk Reporting

July 11, 2025 Jeff Cross

Is Artificial Intelligence Becoming Your Personal Marketing Villain?

July 11, 2025 CMM Staff

Turn Your Business Pitch into a Partnership

Sponsored Articles

Setting a New Standard for Restroom Dispensers
July 3, 2025 Sponsored by Tork, an Essity Brand

Setting a New Standard for Restroom Dispensers

July 3, 2025 Sponsored by SPARTAN CHEMICAL CO.

DfE-Certified Restroom Disinfectant—No PPE Required

July 3, 2025 Sponsored by SOFIDEL AMERICAN CORP

School District Cuts Plumbing Costs With Sofidel

Recent News

EPA Suspends Employees Who Expressed Concerns

EPA Suspends Employees Who Expressed Concerns

Mosquito Season Breeds West Nile Cases

Texas Flood Ranks as The Deadliest US Freshwater Flood in About 50 Years